PG01037 (dihydrochloride)
PG01037 (dihydrochloride) is a potent and selective dopamine D3 receptor antagonist with a Ki of 0.7 nM[1].
Product Specifications
CAS Number
[675599-62-9]
UNSPSC
12352005
Target
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pg01037-dihydrochloride.html
Purity
99.35
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC/C=C/CN1CCN(C2=CC=CC(Cl)=C2Cl)CC1)C3=CC=C(C4=NC=CC=C4)C=C3.[H]Cl.[H]Cl
Molecular Formula
C26H28Cl4N4O
Molecular Weight
554.34
References & Citations
[1]Grundt P, et al. Novel heterocyclic trans olefin analogues of N-{4-[4- (2,3-dichlorophenyl) piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. J Med Chem. 2005 Feb 10;48 (3) :839-48.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
D3 Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6181176-01 0.1 mL
PRDM1 (PR Domain Containing 1, with ZNF Domain, BLIMP1, MGC118922, MGC118923, MGC118924, MGC118925, PRDI-BF1) (HRP)
Ask
View Details 
MBS6181176-02 5x 0.1 mL
PRDM1 (PR Domain Containing 1, with ZNF Domain, BLIMP1, MGC118922, MGC118923, MGC118924, MGC118925, PRDI-BF1) (HRP)
Ask
View Details CSB-EP025484HU-01 20 µg
Recombinant Human Ubiquitin-conjugating enzyme E2 variant 2 (UBE2V2)
Ask
View Details CSB-EP025484HU-02 100 µg
Recombinant Human Ubiquitin-conjugating enzyme E2 variant 2 (UBE2V2)
Ask
View Details 
CSB-EP025484HU-03 1 mg
Recombinant Human Ubiquitin-conjugating enzyme E2 variant 2 (UBE2V2)
Ask
View Details